Skip to main content

Table 1 Preoperative Data

From: Is mitral valve repair superior to replacement for chronic ischemic mitral regurgitation with left ventricular dysfunction?

 

Mitral repair

Mitral replacement

P value

Total number of patients

112

106

 

Age>65 years

75 (66.9%)

77 (72.6%)

NS

Age range (years)

70.6 ± 8.6

71.8 ± 10.8

NS

Female

40 (35.7%)

47 (44.3%)

NS

Hypertension

81(72.3%)

79(74.5%)

NS

Diabetes mellitus

33(29.5%)

34(32.1%)

NS

Hyperlipidemia

80(71.4%)

61(57.5%)

0.032

Smoker

76(67.9%)

81(76.4%)

NS

COPD

21(18.8%)

24(22.6%)

NS

Pulmonary hypertension

38(33.9%)

31(29.2%)

NS

Chronic renal insufficiency

8(7.1%)

6(5.7%)

NS

Peripheral vascular

4(3.6%)

3(2.8%)

NS

Cerebrovascular accident

3(2.7%)

2(1.9%)

NS

Atrial fibrillation

31(27.7%)

28(26.4%)

NS

Previous MI(< 30 days)

12(10.7%)

10(9.4%)

NS

Previous PCI

70(62.5%)

45(42.5%)

0.003

NYHA III-IV

59(52.7%)

52(49.1%)

NS

LVEF < 30%

22 (19.6%)

24 (22.6%)

NS

Echocardiographic data

   

   LVEF (%)

34.6 ± 5.5

35.1 ± 4.3

NS

   LVEDD (mm)

66.29 ± 6.36

65.29 ± 6.36

NS

   LVESD (mm)

50.21 ± 11.08

51.21 ± 11.08

NS

   LAD(mm)

58.04 ± 17.26

57.86 ± 17.15

NS

   SPAP(mmHg)

47.24 ± 14.31

48.01 ± 14.59

NS

Left main disease >50%

36(32.1%)

39(36.8%)

NS

3-vessel disease

91(81.3%)

88(83.0%)

NS

Carpentier classification[6], n (%)

   

   Ia

40(35.7%)

35(33.1%)

NS

   IIIb

72(64.3%)

71(66.9%)

NS

Severe MR(+4), % (n)

69(61.6%)

72(67.9%)

NS

  1. COPD = chronic obstructive pulmonary disease; MI = myocardial infarction; mod = moderate; PCI = percutaneous intervention; NYHA = New York Heart Association; LVEF = left ventricular ejection fraction; LVEDD = left ventricular end-diastolic diameter; LVESD = left ventricular end-systolic diameter; LAD = left atrial diameter; SPAP = systolic pulmonary artery pressure; Left main disease = left main coronary stenosis; 3-vessel disease = triple coronary stenosis; MR = mitral regurgitation NS = not significant;